A.J. Wyble
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Graduate Student Researcher
Research Areas
Biography and Research Information
OverviewAI-generated summary
A.J. Wyble's research focuses on operational aspects and logistical considerations within cell therapy laboratories. Their work investigates the impact of collection goals for autologous hematopoietic progenitor cells (HPCs) on laboratory efficiency and resource management. Wyble has also examined the implications of HPC boosts following chimeric antigen receptor T-cell (CAR-T) therapy, specifically concerning laboratory workflows and storage facility operations.
Wyble's publications explore strategies for optimizing laboratory processes and managing resources effectively in the context of advanced cell therapies. These studies aim to identify efficiencies that can lead to cost savings and improved operational management within healthcare settings that provide these specialized treatments.
Metrics
- Publications: 3
Selected Publications
-
A ROADMAP FOR LARGE-SCALE CELLULAR THERAPY PRODUCT DISPOSAL (2026)
-
AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY (2025)
-
SMALL CHANGES, BIG SAVINGS: IMPACT OF HEMATOPOIETIC PROGENITOR CELLS APHERESIS COLLECTION GOALS ON THE CELL THERAPY LAB (2024)
Collaboration Network
Top Collaborators
- SMALL CHANGES, BIG SAVINGS: IMPACT OF HEMATOPOIETIC PROGENITOR CELLS APHERESIS COLLECTION GOALS ON THE CELL THERAPY LAB
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- A ROADMAP FOR LARGE-SCALE CELLULAR THERAPY PRODUCT DISPOSAL
- SMALL CHANGES, BIG SAVINGS: IMPACT OF HEMATOPOIETIC PROGENITOR CELLS APHERESIS COLLECTION GOALS ON THE CELL THERAPY LAB
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- SMALL CHANGES, BIG SAVINGS: IMPACT OF HEMATOPOIETIC PROGENITOR CELLS APHERESIS COLLECTION GOALS ON THE CELL THERAPY LAB
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- SMALL CHANGES, BIG SAVINGS: IMPACT OF HEMATOPOIETIC PROGENITOR CELLS APHERESIS COLLECTION GOALS ON THE CELL THERAPY LAB
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- A ROADMAP FOR LARGE-SCALE CELLULAR THERAPY PRODUCT DISPOSAL
- A ROADMAP FOR LARGE-SCALE CELLULAR THERAPY PRODUCT DISPOSAL
- A ROADMAP FOR LARGE-SCALE CELLULAR THERAPY PRODUCT DISPOSAL
- A ROADMAP FOR LARGE-SCALE CELLULAR THERAPY PRODUCT DISPOSAL
Similar Researchers
Based on overlapping research topics